Mitigating Risk, Improving Results: A Better Approach to Protocol Deviations
Webinars
Addressing Diversity, Inclusion, and Equitable Participation in Clinical Trials
Beyond Intent: Addressing Diversity, Inclusion, and Equitable Participation in Clinical Trials for Patients and Your Business
Diversity, Inclusion, and Equitable participation (DI&E) are the cornerstones of a successful clinical trial and a thriving business. This need is further underscored by the proposed FDA Diverse and Equitable Participation in Clinical Trials (DEPICT) Act, which challenges our industry to go beyond intent and get real about ‘how’ we can make a meaningful difference.
Come and learn from our distinguished faculty how Pharmaceutical Companies, CROs, Vendors, and Health Care Providers are addressing this challenge to ensure patients are not denied potential life-changing treatments.
Key Questions to Discuss and to Consider
- What are the risks of not shifting from intent to action (for Sponsor, Vendor, CRO and HCP)?
- What are the key challenges and how are you addressing these within your business?
- What role does effective oversight play in ultimate success?
- How will true success look like in clinical trials and across all aspects of the life science industry?
Agenda
- Diversity, Inclusion, and Equitable participation (DI&E) are the cornerstones of a successful clinical trial and a thriving business. This need is further underscored by the proposed FDA Diverse and Equitable Participation in Clinical Trials (DEPICT) Act, which challenges our industry to go beyond intent and get real about ‘how’ we can make a meaningful difference. Come and learn from our distinguished faculty how Pharmaceutical Companies, CROs, Vendors, and Health Care Providers are addressing this challenge to ensure patients are not denied potential life-changing treatments.
- Proposed DEPICT act expectations
- Approaches to ensure effective recruitment and retention of under-represented participants
- How ClinEco helps select, compare, and partner with diverse organizations
Presenters
Clinical Operations Consultant and Co-Founder, ClinOpsClarity
Jason Gubb has more than 25 years of experience in global clinical operations strategy and leadership. He has an applied knowledge of leveraging internal and external data, analytics, digital technology and collaborative partnerships to create actionable insights for study teams. Mr. Gubb works with startups, pharma, vendors and contract research organizations (CROs) to develop innovative approaches to optimize protocol designs, modernize clinical trial conduct and accelerate trial delivery.
Former Chief Marketing Officer, eClinical Solutions
Sheila has more than 20 years of industry experience including marketing, product management and strategy roles in life sciences technology companies. She spent 15 years at PHT Corporation (now ERT) in a variety of marketing and executive leadership roles helping to drive the company’s growth and the industry adoption of electronic clinical outcome assessments (eCOA). At eClinical Solutions, Sheila managed all aspects of marketing including branding, communications, lead generation and product marketing. She enjoys finding creative ways to tell customer stories, and building products and services that help clinicians, data scientists and technologists do the challenging and important work of bringing life-saving new therapies to market.
